You searched for metabolic diseases - Page 48 of 64

News and Trends 13 Aug 2018

Orchard Therapeutics Raises €132M to Develop Gene Therapies

…most advanced clinical programs, which aim to treat rare inherited metabolic and immune system diseases. The news follows Orchard’s acquisition of GSK’s entire gene therapy portfolio last year, including Strimvelis,…

August 13, 2018 - 2 minutesmins - By Alexander Burik

Orchard therapeutics gene therapy header

News and Trends 23 Apr 2020

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

…treatments to tackle a range of rare genetic diseases such as inflammatory skin conditions and metabolic disorders. Genespire received €16M of the funding, though the precise amounts received by the…

April 23, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 18 Apr 2017

Two Big Pharma Players Team up to Take Over the NASH Space

…compounds attack the metabolic stages of NASH and as Marco Boorsma, a partner at Forbion Partners told us in our recent NASH review: FXR has been a target of great…

April 18, 2017 - 3 minutesmins - By Melanie De Almeida

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

…the potentially life-threatening liver condition metabolic dysfunction-associated steatohepatitis (MASH), Rezdiffra received the green light from the U.S. Food and Drug Administration (FDA) to treat the disease back in March. MASH…

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

…drugs for metabolic diseases, before Sanofi then in-licensed one of the candidates in 2019. As it turned out, 2022 brought with it three more major AI deals for Sanofi. These…

November 2, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 11 Aug 2016

This new Phase III Failure adds up to AstraZeneca’s Troubles

…was killing 6 programs. The cuts include small molecule programs for cardiometabolic diseases (such as NASH) and an antibody for asthma, but also several of MedImmune’s new identities for solid…

August 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

In Depth 30 Oct 2018

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

…with Danish diabetes giant, Novo Nordisk, to further develop their blood–brain barrier shuttle technology focussing on diabetes and metabolic diseases. Stowing drugs in exosome bubbles Over the past 10 years,…

October 30, 2018 - 7 minutesmins - By External Contributor

News and Trends 20 Mar 2017

French Biotech fails Second Phase II Trial for Cardiovascular Disease

…cardiovascular and metabolic diseases. The company now presented data on its lead candidate CER-001, which was investigated in a Phase II study for the treatment of patients with post-acute coronary…

March 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 24 Feb 2023

Beyond Biotech podcast 35: Rare Disease Day

…chronic medical conditions including autoimmune and metabolic diseases to improve the lives of patients. GRObio is applying its platform to advance partnered and collaborative programs, as well as its own…

February 24, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jan 2022

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

…of bispecific small molecule drugs for metabolic diseases, with Sanofi in-licensing one of the candidates in 2019. As part of the new deal, Exscientia will screen patient tissue data with…

January 11, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Jan 2023

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy

…discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno-oncology…

January 20, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 20 Jan 2023

DeuterOncology closes financing round to start lung cancer study

…overcomes this at source, having a metabolically-liable hydrogen replaced with a stronger bond strength deuterium atom. This significantly reduces the impact of this metabolic liability during treatment. The strength of…

January 20, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Orchard Therapeutics Raises €132M to Develop Gene Therapies

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

Two Big Pharma Players Team up to Take Over the NASH Space

The 2024 drug approval list: Eight new treatments you should know about

How French pharma giant Sanofi is betting big on AI

This new Phase III Failure adds up to AstraZeneca’s Troubles

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

French Biotech fails Second Phase II Trial for Cardiovascular Disease

Beyond Biotech podcast 35: Rare Disease Day

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy

DeuterOncology closes financing round to start lung cancer study

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!